Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Half-year Report

March 25, 2019
Download  full announcement   Renalytix AI plc (AIM: RENX), the AIM quoted developer of artificial intelligence-enabled diagnostics for kidney disease, announces its inaugural unaudited interim results for the six months ended 31 December 2018. Operational highlights Secured agreements for 

Appointment of Nomad and Joint Broker

February 14, 2019
Download  full announcement   Further to the announcement on 20 December 2018, Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled diagnostics for kidney disease, announces the appointment of Stifel as the Company’s nominated adviser and joint broker with immediate effect.

Clarification re. lock-up restrictions for Distribution Shares

January 21, 2019
Download  full announcement   This announcement relates solely to ordinary shares in the Company which were distributed to certain qualifying shareholders owning EKF Diagnostic Holdings plc shares prior to admission (the “Distribution Shares”). Holders of Distribution Shares are reminded that these
Displaying 201 - 210 of 224